Typical signs of oncocytic papillary renal cell carcinoma in everyday clinical praxis
Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- adrenalektomie MeSH
- biopsie MeSH
- buněčná diferenciace MeSH
- karcinom z renálních buněk diagnostické zobrazování patologie chirurgie MeSH
- lidé středního věku MeSH
- lidé MeSH
- nádory ledvin diagnostické zobrazování patologie chirurgie MeSH
- nefrektomie MeSH
- nekróza MeSH
- oxyfilní adenom diagnostické zobrazování patologie chirurgie MeSH
- papilární karcinom diagnostické zobrazování patologie chirurgie MeSH
- počítačová rentgenová tomografie MeSH
- senioři MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
PURPOSE: Types 1 and 2 by Delahunt of papillary renal cell carcinoma (PRCC) are traditionally differentiated. An oncocytic variant of PRCC (O-PRCC) has recently been described. We compare clinical data of O-PRCC with other subtypes of PRCC such as the main tumour size, necrotic changes, presence of pseudocapsula and real extrarenal growth in retrospective study. METHODS: From 1/1992 to 10/2009, 1,398 patients with 1,436 renal tumours were surgically treated in our institution. PRCCs were described in 109 (7.6%). Among PRCC, O-PRCCs were in 12 (11%), PRCC type 1 in 86 (78.9%), PRCC type 2 in 8 (7.3%) and others in 3 (2.8%) cases. RESULTS: The patient's mean age with O-PRCC (M:F ratio = 2:1) was 67.5 +/- 10.9 versus 63.5 +/- 14.1 in type 1 and 57.9 +/- 5.7 in type 2, the mean tumour size was 35 +/- 12 mm versus 47 +/- 22 and 37 +/- 17, respectively. The follow-up of O-PRCC is 35.3 +/- 12.3 months and all cases are without recurrence. We did not find any pseudocapsula in O-PRCC but it was a major sign of PRCC type 1 (32.6%). Huge microscopic necrotic changes were described in 33.3% of O-PRCC, in 33.7% of PRCC type 1 and 62.5% of PRCC type 2. Extrarenal growth was found only in 16.7% O-PRCC versus 40.7% in PRCC type I. CONCLUSIONS: None of the O-PRCC had pseudocapsula and none had massive necroses in comparison of O-PRCC with PRCC types I and II. Extrarenal growth in O-PRCC is relatively rare. The malignant potential of O-PRCC is low.
Zobrazit více v PubMed
Hum Pathol. 2001 Jun;32(6):590-5 PubMed
Cancer Res. 2005 Jul 1;65(13):5628-37 PubMed
Transplant Proc. 2008 Dec;40(10):3354-8 PubMed
Hum Pathol. 2008 Jan;39(1):96-101 PubMed
Pathol Int. 2009 Mar;59(3):137-46 PubMed
Am J Pathol. 1998 Nov;153(5):1467-73 PubMed
Scand J Urol Nephrol. 2004;38(6):481-4 PubMed
Am J Surg Pathol. 2005 Dec;29(12):1576-81 PubMed
J Urol. 2003 Sep;170(3):764-7 PubMed
Pathol Int. 2008 May;58(5):300-5 PubMed
Am J Pathol. 2001 May;158(5):1639-51 PubMed
Urology. 2007 Feb;69(2):230-5 PubMed
Urology. 2005 Sep;66(3):484-8 PubMed
Mod Pathol. 1997 Jun;10(6):537-44 PubMed
Ann Diagn Pathol. 2006 Jun;10(3):133-9 PubMed
Eur J Radiol. 2007 May;62(2):295-301 PubMed
BJU Int. 2006 Jul;98(1):63-6 PubMed
Pathol Int. 2008 Mar;58(3):164-8 PubMed
Cancer. 1976 Dec;38(6):2469-80 PubMed
Complete laparoscopic nephroureterectomy with intravesical lockable clip
